bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Rani Therapeutics Inc. logo

    Rani Therapeutics Inc.

    RANI | undefined
    Chart Builder DCF Calculator
    -
    At close: undefined
    -
    After-hours:
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $51.56M
    Enterprise Value
    $1.72M
    Beta
    0.71
    Average Volume
    875.82K
    Shares Outstanding (Diluted)
    187.17M
    Shares Change YoY
    412.2%
    Institutional Ownership
    23.75%
    Exchange
    NASDAQ
    ISIN
    US7530181004

    Price Performance

    Price Change 1M
    -10.2%
    Price Change 3M
    4.6%
    Price Change 6M
    -30.7%
    Price Change YTD
    -41.9%
    Price Change 1Y
    59.1%
    Price Change 3Y
    -71.6%
    Price Change 5Y
    -95.6%
    1M CAGR (ann.)
    -0.3%
    1Y CAGR (ann.)
    63.9%
    5Y CAGR (ann.)
    -48.3%
    All-Time CAGR
    -40.0%

    Valuation

    PE Ratio
    -2.93
    Forward PE
    N/A
    PEG Ratio
    -0.02
    Forward PEG
    -0.34
    PS Ratio
    16.27
    Forward PS
    7.80
    PB Ratio
    1.31
    P/FCF Ratio
    -2.54
    P/Adj. FCF Ratio
    -1.75
    P/OCF Ratio
    -7.18
    EV/Sales
    0.54
    EV/EBIT
    -0.07
    EV/EBITDA
    -0.05
    EV/FCF
    -0.08
    Earnings Yield
    -34.2%
    FCF Yield
    -39.4%
    Adj. FCF Yield
    -57.1%

    Financial Health

    Net Cash
    $49.84M
    Total Debt
    $3.55M
    Cash & Short-Term Investments
    $53.39M
    Total Assets
    $60.84M
    Current Ratio
    5.31
    Quick Ratio
    5.31
    Debt / Equity Ratio
    0.09
    Debt / EBITDA
    -0.11
    Debt / FCF
    -0.17
    OCF / Debt
    -5.72
    Interest Coverage
    -28.22
    Altman Z-Score
    -1.31
    Piotroski F-Score
    4

    Margins & Profitability

    Gross Profit Margin
    96.7%
    Operating Profit Margin
    -1040.0%
    EBITDA Margin
    -658.2%
    Net Profit Margin
    -618.0%
    FCF Margin
    -641.8%
    Adj. FCF Margin
    -928.6%
    SBC / Revenue
    186.4%
    SBC Impact (per share)
    -44.7%

    Returns

    Return on Assets
    -49.5%
    Return on Equity
    -129.9%
    Return on Invested Capital
    -64.0%
    Return on Capital Employed
    -65.7%
    Return on Tangible Assets
    -49.5%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    108.8%
    Revenue CAGR 5Y
    0.9%
    Revenue CAGR 10Y
    N/A
    EPS CAGR 3Y
    57.8%
    EPS CAGR 5Y
    20.7%
    EPS CAGR 10Y
    N/A
    FCF CAGR 3Y
    39.4%
    FCF CAGR 5Y
    17.4%
    FCF CAGR 10Y
    N/A

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    7
    EPS Growth Next 3Y
    9.9%
    Revenue Growth Next 3Y
    68.2%
    Earnings Date
    Nov 4, 2026
    EPS Estimate (next Q)
    -$0.05
    EPS Growth Est (next Q)
    -58.3%
    Revenue Est (next Q)
    $1.28M
    Revenue Growth Est (next Q)
    N/A

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $15.67
    Price Target Upside
    1883.5%

    Cash Flow

    Operating Cash Flow
    $-20.29M
    Free Cash Flow
    $-20.34M
    Adj. Free Cash Flow
    $-29.43M
    FCF Per Share
    -$0.11
    OCF Per Share
    -$0.11
    OCF/S Ratio
    -416.1%

    Income Statement

    Revenue
    $3.17M
    Gross Profit
    $3.01M
    Operating Income
    $-32.96M
    EBITDA
    $-32.1M
    Net Income
    $-30.14M
    EPS (Diluted)
    -$0.27
    Revenue / Employee
    $45.27K
    Profit / Employee
    $-430.59K
    Employees
    70

    © 2026 bestshares.com. All rights reserved.